Notch, apoptosis and cancer

Advances in Experimental Medicine and Biology

Volumn 727, Issue , 2012, Pages 199-209

  Dang, Thao P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL FATE; CELL GROWTH; CELL SURVIVAL; ENZYME ACTIVATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; NEOPLASMS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84859485240     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0899-4_15     Document Type: Article

References (73)

1. Ken JF, Wyllie AH, Cunie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br I Cancer 1972; 26:239-257.
2. Danial Nika N, Korsmeyer Stanley J. Cell death: Critical control points. Cell 2004; 116:205-219.
3. Bredesen Dale E, Rao Rammohan V, Mehlen Patrick. Cell death in the nervous system. Nature 2006; 443: 796-802.
4. Chang Mi-Kyung, Binder Christoph J, Miller Yury Jet al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004; 200:1359-1370.
5. Cory S, Strasser A, Jacks T et al. Enhanced cell survival and tumorigenesis Cold Spring Harb Symp. Quant Biol 1994; 59:365-375.
6. Morgan TH. The Theory of the Gene. The American Naturalist 1917; 51:513.
7. Wharton KA, Johansen KM, Xu T et al. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 1985; 43:567-581.
8. Shellenbarger DL, Mohler JD. Temperature-sensitive periods and autonomy of pleiotropic effects of 10) Ntsl, a conditional notch lethal in Drosophila. Dcv Biol 1978; 62:432-446.
9. Roy Monideepa, Pear Wanen S, Aster Jon C. The multifaceted role of Notch in cancer. Cun Opin Genet Dcv 2007; 17:52-59.
10. Cuny Christine L, Reed Laura L, Golde Todd E et al. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene 2005; 24:6333-6344.
11. Das Indranil, Craig Colleen, Funahashi Yasuhiro et al. Notch oncoproteins depend on gamma-secretase presenilin activity for processing and function. J Biol Chem 2004; 279:30771-30780.
12. Duechler M, Shehata M, Schwarzmeier JD et al. Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated x4ith downregulation of CD23 and inactivation of Notch2. Leukemia 2005; 19: 260-267.
13. Haruki Nobuhiro, Kawaguchi Keiko S, Eichenberger Shannon et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res 2005; 65:3555-3561.
14. Konishi Jun, Kawaguchi Keiko S, Vo Huan et al. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 2007; 67:8051-8057.
15. Osipo C, Patel P, Rizzo P et al. ErbB-2 inhibition activates Notch-i and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene 2008; 27:50 19-5032.
16. Pannequin Julie, Bonnans Caroline, Delaunay Nathalie et al. The wnttargetjagged-1 mediates the activation of notch signaling by progastrin in human colorectal cancer cells. Cancer Res 2009; 69:6065-6073.
17. Vousden Karen H, Lane David P. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8:275-283.
18. Hollstein M, Sidransky D, Vogelstein Bet al. p53 mutations in human cancers. Science 1991; 253:49-53.
19. Sanchez-Cespedes M, Reed AL, Buta Metal. Inactivation of the INK4AJARF locus frequently coexists ith 1 P53 mutations in nonsmall cell lung cancer. Oncogene 1999; 18:543-5X49.
20. Higashiyama M, Doi O, Kodama K et al. MDM2 gene amplification and expression in nonsmall-cell lung cancer: Immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation. Br J Cancer 1997; 75:1302-1308.
21. Ladanyi M, Cha C, Lewis R et al. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993; 53:16-18.
22. Beverly Levi J, FelsherDeanW, CapobiancoAnthony J. Suppressionofps3 byNotch inlymphomagenesis: Implications for initiation and regression. Cancer Res 2005; 65:7159-7168.
23. Kim SB, Chae OW, Lee J et al. Activated Notchi interacts with p53 to inhibit its phosphorylation and transactivation Cell Death Differ. 2007; 14:982-991.
24. Boggs Kristy, Henderson Brystol, Reisman David. RBP-Jkappa binds to and represses transcription of the p53 tumor suppressor gene. Cell Biol Tnt 2009; 33:318-324.
25. Gulino Alberto, Di Marcotullio Lucia, Screpanti Isabella. The multiple functions of Numb Exp. Cell Res 2010; 316:900-906.
26. Westhoff Britta, Colaluca Ivan N, D'Ario Giovanni et al. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci USA 2009; 106:22293-22298.
27. Pece Salvatore, Senesi Michela, Santolini Elisa et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004; 167:215-221.
28. Colaluca Ivan N, Tosoni Daniela, Nuciforo Paolo et al. NUMB controls p53 tumour suppressor activity. Nature 2008; 451:76-80.
29. Wang Chunmei, Qi Runzi, Li Nan et al. Notchi signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. J Biol Chem 2009; 284:16183-16190.
30. Yang Xudong, Klein Rudiger, Tian Xiaolin et al. Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dcv Biol 2004; 269:81-94.
31. Lefort Karine, Mandinova Anna, Ostano Paola et al. Notchi is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1 2 and MRCKalpha kinases. Genes Dcv 2007; 21:562-577.
32. Alimirah Fatouma, Panchanathan Ravichandran, Davis Francesca J et al. Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch 1: Implications for cancer cell fate determination after genotoxic stress. Neoplasia 2007; 9:427-434.
33. Wei Chia-Lin, Wu Qiang, Vega Vinsensius B et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207-2 19.
34. Bassères DS, Baldwin AS. Nuclear factor-kappaB and inhibitor ofkappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25:6817-6830.
35. White DW, Roy A, Gilmore TD. The v-Rd oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells. Oncogene 1995; 10:857-868.
36. Beg AA, Sha WC, Bronson RT et al. Embryonic lethality and liver degeneration in mice lacking the ReLA. component of NF-kappa B. Nature 1995; 376:167-170.
37. Oswald F, Liptay S, Adler G et al. NF-kappaB2 is a putative target gene of activated Notch-i via RBP-Jkappa. Mol Cell Biol 1998; 18:2077-2088.
38. Cheng P, Zlobin A, Volgina V et al. Notch-i regulates NF-kappaB activity in hemopoietic progenitor cells. J Tmmunol 2001; 167:4458-4467.
39. Oakley Fiona, Mann Jelena, Ruddell Richard Get al. Basal expression oflkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator. Notchi J Biol Chem 2003; 278:24359-24370.
40. Bash J, Zong WX, Banga S et al. Re1iNF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jaggedi, a ligand for Notch receptors. EMBO J 1999; 18:2803-2811.
41. Moran Stewart T, Cariappa Annaiah, Liu Haoyuan et al. Synergism between NF-kappa Bi p50 and Notch2 during the development of marginal zone B lymphocytes. J Immunol 2007; 179:195-200.
42. Guan E, Wang J, Laborda Jet al. T-cell leukemia-associatedhuman Notch translocation-associatedNotch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in I-cells. J Exp Med 1996; 183:2025-2032.
43. Wang J, Shelly L, Miele Let al. Human Notch-i inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J Tmmunol 2001; 167:289-295.
44. Shin Hyun Mu, Minter Lisa M, Cho Ok Hyun et al. Notch 1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 2006; 25:129-138.
45. Vilimas Tomas, Mascarenhas Joaquina, Palomero Teresa et al. Targeting the NF-kappaB signaling pathway in Notch1-induced I-cell leukemia. Nat Med 2007; 13:70-77.
46. Fernández-Majada V, Aguilera C, Villanueva A et al. Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci USA 2007; 104:276-281.
47. Paez Juan, Sellers William R. P13K PTEN AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 2003; 115:145-167.
48. Keniry M, Parsons R. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 2008; 27:5477-5485.
49. Rangarajan A, Syal R, Selvarajah S et al. Activated Notchi signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB Akt. Virology 2001; 286:23-30.
50. Konishi J, Yi F, Chen X et al. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of him. Oncogene 2010; 29:589-596.
51. Stylianou Spyros, Clarke Rob B, Brennan Keith. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006; 66:1517-1525.
52. Meurette Olivier, Stylianou Spyros, Rock Rebecca et al. Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res 2009; 69:50 15-5022.
53. Bedogni Barbara, Warneke James A, Nickoloff Brian J et al. Notchi is an effector of Akt and hypoxia in melanoma development. J Clin Invest 2008; 118:3660-3670.
54. Palomero Teresa, Sulis Maria Luisa, Cortina Maria et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13:1203-1210.
55. Perumalsamy Lakshmi R, Nagala Manjula, Sarin Apurva. Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival. Proc Natl Acad Sci USA 2010; 107:6882-6887.
56. Eliasz S, Liang S, Chen Yet al. Notch-i stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IOF-1R pathway. Oncogene 2010; 29:2488-2498.
57. Williams O, Norton T, Halligey M et al. The action of Bax and bcl-2 on T-cell selection. J Exp Med 1998; 188:1125-1133.
58. Hamnér S, Skoglosa Y, Lindholm D. Differential expression of bcl-w and bcl-x messenger RNA in the developing and adult rat nervous system. Neuroscience 1999; 9 1:673-684.
59. Bouillet Philippe, Strasser Andreas. BH3-only proteins evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 2002; 115:1567-1574.
60. Monow David, Sweeney Catherine, Birney Yvonne A. et al. Cyclic strain inhibits Notch receptor signaling in vascular smooth muscle cells in vitro. Circ Res 2005; 96:567-575.
61. Wang Zhiwei, Zhang Yuxiang, Li Yiwei et al. Down-regulation of Notch-i contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006; 5:483-493.
62. Sade Hadassah, Krishna Sudhir, Sarin Apurva. The anti-apoptotic effect of Notch-i requires pSolckdependent, Akt PKB-mediated signaling in T-cells. J Biol Chem 2004; 279:2937-2944.
63. NefedovaYulia, SullivanDaniel M, Bolick Sophia C et al. InhibitionofNotch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008; 111:2220-2229.
64. Qin Jian-Zhong, Stennett Lawrence, Bacon Patricia et al p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Mol Cancer Ther 2004; 3:895-902.
65. WilsonNicholas S, Dixit Vishva, Ashicenazi Avi. Death receptor signal transducers: Nodes ofcoordination in immune signaling networks. Nat Immunol 2009; 10:348-355.
66. Quillard Thibaut, Devalliere Julie, Chatelais Mathias et al. Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule survivin. PLoS One 2009; 4:e8244.
67. Bushell Martin, Stoneley Mark, Kong Yi Wen et al. Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell 2006; 23:401-412.
68. Wang Wenli, Prince Chengyu Z, Mou Yongshan et al. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK MAPK activation. Resistance to Fas ligand-induced apoptosis. J Biol Chem 2002; 277:21723-21729.
69. Bheeshmachar Geetha, Purushotaman Divya, Sade Hadassah et al. Evidence for a role for notch signaling in the cytokine-dependent survival of activated T-cells. J Immunol 2006; 177:5041-5050.
70. O'Riordan Mary XD, Bauler Laura D, Scott Fiona Let al. Inhibitor of apoptosis proteins in eukaryotic evolution and development: A model of thematic conservation. Dcv Cell 2008; 15:497-508.
71. Rosati Emanuela, Sabatini Rita, Rampino Giuliana et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009; 113:856-865.
72. Liu Wen-Hsien, Hsiao Huey-Wen, Tsou Wen-I et al. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J 2007; 26:1660-1669.
73. Jemal Ahmedin, Siegel Rebecca, Ward Elizabeth et al. Cancer statistics, 2009 CA. Cancer J Clin 2009; 59: 225-249.